Femasys is trading 5.6% up at $2.83 after rebounding from the September 8, 2026 close of $2.68.
- No new company-specific announcement for September 9, 2026 was identified.
- Latest listed developments were the August 26 UNC Health partnership and September 3 registration of 28.12 million shares for resale; major U.S. indexes were modestly lower, without a clear market-wide catalyst.